---
figid: PMC3479318__nihms-360091-f0006
figlink: /pmc/articles/PMC3479318/figure/F6/
number: Figure 6
caption: Speculative Scenario of NNK-activated β-adrenergic Signaling Suppressed by
  Apigenin NNK binds to the β-adrenergic receptor (β-AR) that subsequently activates
  focal adhesion kinase (FAK) and Src to elicit the activation of the mitogenic activated
  protein kinase (MAPK) pathway. MAPK pathway involves activation of Ras/Raf/MEK resulting
  in the activation of ERK. Both the synthetic drug propranolol and the phytochemical
  apigenin appears to inhibit NNK activation of β-AR at the receptor level.
pmcid: PMC3479318
papertitle: Apigenin Inhibits NNK-induced Focal Adhesion Kinase Activation in Pancreatic
  Cancer Cells.
reftext: Hung Pham, et al. Pancreas. ;41(8):1306-1315.
pmc_ranked_result_index: '3376'
pathway_score: 0.9319378
filename: nihms-360091-f0006.jpg
figtitle: Apigenin Inhibits NNK-induced Focal Adhesion Kinase Activation in Pancreatic
  Cancer Cells.
year: ''
organisms: Homo sapiens
ndex: 6def8448-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3479318__nihms-360091-f0006.html
  '@type': Dataset
  description: Speculative Scenario of NNK-activated β-adrenergic Signaling Suppressed
    by Apigenin NNK binds to the β-adrenergic receptor (β-AR) that subsequently activates
    focal adhesion kinase (FAK) and Src to elicit the activation of the mitogenic
    activated protein kinase (MAPK) pathway. MAPK pathway involves activation of Ras/Raf/MEK
    resulting in the activation of ERK. Both the synthetic drug propranolol and the
    phytochemical apigenin appears to inhibit NNK activation of β-AR at the receptor
    level.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - HRAS
  - BRAF
  - MAPK3
  - KRAS
  - MAP2K1
  - MAPK1
  - PTK2
  - RAF1
  - NRAS
  - TFPI
  - ARAF
  - SRC
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: EPI
  symbol: EPI
  source: hgnc_alias_symbol
  hgnc_symbol: TFPI
  entrez: '7035'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
